ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för ospemifene. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

20 träffar

Bibliografisk träff 2013-06-01

Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy.

Portman DJ, Bachmann GA, Simon JA, Ospemifene Study Group.

Menopause · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1097/gme.0b013e318279ba64

Bibliografisk träff 2013-05-01

The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice.

Maximov PY, Lee TM, Jordan VC.

Curr Clin Pharmacol · comparative study; research support, non-u.s. gov't; research-article; review; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.2174/1574884711308020006

Bibliografisk träff 2013-04-01

One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus.

Simon JA, Lin VH, Radovich C, Bachmann GA, Ospemifene Study Group.

Menopause · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1097/gme.0b013e31826d36ba

Bibliografisk träff 2013-01-16

Ospemifene, vulvovaginal atrophy, and breast cancer.

Wurz GT, Soe LH, DeGregorio MW.

Maturitas · review; journal article · DOI 10.1016/j.maturitas.2012.12.002

Bibliografisk träff 2012-01-01

Selective oestrogen receptor modulators decrease the inflammatory response of glial cells.

Arevalo MA, Diz-Chaves Y, Santos-Galindo M, Bellini MJ, Garcia-Segura LM.

J Neuroendocrinol · research support, non-u.s. gov't; review; journal article · DOI 10.1111/j.1365-2826.2011.02156.x

Bibliografisk träff 2012-01-01

Ospemifene and 4-hydroxyospemifene effectively prevent and treat breast cancer in the MTag.Tg transgenic mouse model.

Burich RA, Mehta NR, Wurz GT, McCall JL, Greenberg BE, Bell KE, Griffey SM, DeGregorio MW.

Menopause · research-article; journal article; research support, n.i.h., extramural · DOI 10.1097/gme.0b013e318223e82a

Bibliografisk träff 2012-01-01

Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review.

Tan O, Bradshaw K, Carr BR.

Menopause · review; journal article · DOI 10.1097/gme.0b013e31821f92df

Bibliografisk träff 2011-12-22

An update on selective estrogen receptor modulators for the prevention and treatment of osteoporosis.

Komm BS, Chines AA.

Maturitas · research support, non-u.s. gov't; review; journal article · DOI 10.1016/j.maturitas.2011.11.018

Bibliografisk träff 2011-06-01

Selective estrogen receptor modulators: the future in menopausal treatment.

Palacios S.

Minerva Ginecol · journal article

Bibliografisk träff 2010-10-01

Anti-breast cancer potential of SS1020, a novel antiestrogen lacking estrogenic and genotoxic actions.

Laxmi YR, Liu X, Suzuki N, Kim SY, Okamoto K, Kim HJ, Zhang G, Chen JJ, Okamoto Y, Shibutani S.

Int J Cancer · journal article; research support, n.i.h., extramural · DOI 10.1002/ijc.25167

Bibliografisk träff 2010-06-01

Pharmacologic evaluation of ospemifene.

McCall JL, DeGregorio MW.

Expert Opin Drug Metab Toxicol · review; journal article · DOI 10.1517/17425255.2010.487483

Bibliografisk träff 2010-05-01

Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study.

Bachmann GA, Komi JO, Ospemifene Study Group.

Menopause · clinical trial, phase iii; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1097/gme.0b013e3181c1ac01

Bibliografisk träff 2010-05-01

Endometrial safety: a key hurdle for selective estrogen receptor modulators in development.

Pinkerton JV, Goldstein SR.

Menopause · research support, non-u.s. gov't; review; journal article · DOI 10.1097/gme.0b013e3181c4f1d6

Bibliografisk träff 2010-03-01

SERMs in the prevention and treatment of postmenopausal osteoporosis: an update.

Kulak Júnior J, Kulak CA, Taylor HS.

Arq Bras Endocrinol Metabol · research-article; review; journal article · DOI 10.1590/s0004-27302010000200016

Bibliografisk träff 2010-01-01

Selective estrogen receptor modulators decrease the production of interleukin-6 and interferon-gamma-inducible protein-10 by astrocytes exposed to inflammatory challenge in vitro.

Cerciat M, Unkila M, Garcia-Segura LM, Arevalo MA.

Glia · research support, non-u.s. gov't; journal article · DOI 10.1002/glia.20904

Bibliografisk träff 2009-10-01

Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis.

Lewiecki EM.

J Womens Health (Larchmt) · research support, non-u.s. gov't; review; journal article · DOI 10.1089/jwh.2008.1086

Bibliografisk träff 2009-06-01

Ospemifene use in postmenopausal women.

Gennari L, Merlotti D, Valleggi F, Nuti R.

Expert Opin Investig Drugs · review; journal article · DOI 10.1517/13543780902953715

Bibliografisk träff 2009-05-01

Designing the ideal selective estrogen receptor modulator--an achievable goal?

Taylor HS.

Menopause · research support, non-u.s. gov't; research-article; journal article · DOI 10.1097/gme.0b013e3181906fa3

Bibliografisk träff 2001-06-01

In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancer.

Taras TL, Wurz GT, DeGregorio MW.

J Steroid Biochem Mol Biol · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1016/s0960-0760(01)00066-8

Bibliografisk träff 2000-03-01

Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene.

Hellmann-Blumberg U, Taras TL, Wurz GT, DeGregorio MW.

Breast Cancer Res Treat · comparative study; research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1023/a:1006311214152